These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 36525605

  • 1. Sex differences in systemic lupus erythematosus (SLE): an inception cohort of the Chinese SLE Treatment and Research Group (CSTAR) registry XVII.
    Gui Y, Bai W, Xu J, Duan X, Zhan F, Zhao C, Jiang Z, Li Z, Wu L, Liu S, Yang M, Wei W, Wang Z, Zhao J, Wang Q, Leng X, Tian X, Li M, Zhao Y, Zeng X, CSTAR co-authors.
    Chin Med J (Engl); 2022 Sep 20; 135(18):2191-2199. PubMed ID: 36525605
    [Abstract] [Full Text] [Related]

  • 2. Chinese Systemic Lupus Erythematosus Treatment and Research Group (CSTAR) Registry XI: gender impact on long-term outcomes.
    Zhang S, Ye Z, Li C, Li Z, Li X, Wu L, Liu S, Zuo X, Zhu P, Wang Z, Wang Y, Wang Z, Zhao J, Wang Q, Tian X, Li M, Zeng X.
    Lupus; 2019 Apr 20; 28(5):635-641. PubMed ID: 30939980
    [Abstract] [Full Text] [Related]

  • 3. Chinese SLE Treatment and Research group (CSTAR) registry VII: prevalence and clinical significance of serositis in Chinese patients with systemic lupus erythematosus.
    Zhao J, Bai W, Zhu P, Zhang X, Liu S, Wu L, Ma L, Bi L, Zuo X, Sun L, Huang C, Tian X, Li M, Zhao Y, Zeng X, CSTAR co-authors.
    Lupus; 2016 May 20; 25(6):652-7. PubMed ID: 26762471
    [Abstract] [Full Text] [Related]

  • 4. Chinese SLE Treatment and Research group (CSTAR) registry: V. gender impact on Chinese patients with systemic lupus erythematosus.
    Zhang S, Su J, Li X, Zhang X, Liu S, Wu L, Ma L, Bi L, Zuo X, Sun L, Huang C, Zhao J, Li M, Zeng X, CSTAR co-authors.
    Lupus; 2015 Oct 20; 24(12):1267-75. PubMed ID: 25972364
    [Abstract] [Full Text] [Related]

  • 5. Severe disease presentation and poor outcomes among pediatric systemic lupus erythematosus patients in South Africa.
    Lewandowski LB, Schanberg LE, Thielman N, Phuti A, Kalla AA, Okpechi I, Nourse P, Gajjar P, Faller G, Ambaram P, Reuter H, Spittal G, Scott C.
    Lupus; 2017 Feb 20; 26(2):186-194. PubMed ID: 27488473
    [Abstract] [Full Text] [Related]

  • 6. Lupus glomerulonephritis in 788 Chinese children: a multi-centre clinical and histopathological analysis based on 549 renal biopsies.
    Jin SY, Huang DL, Dang XQ, Yi ZW.
    Paediatr Int Child Health; 2017 Nov 20; 37(4):286-291. PubMed ID: 28463080
    [Abstract] [Full Text] [Related]

  • 7. Chinese SLE Treatment and Research group (CSTAR) registry: Clinical significance of thrombocytopenia in Chinese patients with systemic lupus erythematosus.
    Jiang N, Li M, Zhang M, Xu J, Jiang L, Gong L, Wu F, Gu J, Zhao J, Xiang Y, Wang Z, Zhao Y, Zeng X, CSTAR co-authors.
    PLoS One; 2019 Nov 20; 14(11):e0225516. PubMed ID: 31747435
    [Abstract] [Full Text] [Related]

  • 8. Long-term renal survival of paediatric patients with lupus nephritis.
    Demir S, Gülhan B, Özen S, Çeleğen K, Batu ED, Taş N, Orhan D, Bilginer Y, Düzova A, Ozaltin F, Topaloğlu R.
    Nephrol Dial Transplant; 2022 May 25; 37(6):1069-1077. PubMed ID: 33826705
    [Abstract] [Full Text] [Related]

  • 9. Worse Renal Presentation and Prognosis in Initial-Onset Lupus Nephritis than Early-Onset Lupus Nephritis.
    Kwon OC, Park JH, Lee SW, Song JJ, Park YB, Park MC.
    Yonsei Med J; 2020 Nov 25; 61(11):951-957. PubMed ID: 33107238
    [Abstract] [Full Text] [Related]

  • 10. Systemic lupus erythematosus in Spanish males: a study of the Spanish Rheumatology Society Lupus Registry (RELESSER) cohort.
    Riveros Frutos A, Casas I, Rúa-Figueroa I, López-Longo FJ, Calvo-Alén J, Galindo M, Fernández-Nebro A, Pego-Reigosa JM, Olivé Marqués A, RELESSER Group, part of the Spanish Society of Rheumatology Systemic Autoimmune Diseases Study Group (EASSER).
    Lupus; 2017 Jun 25; 26(7):698-706. PubMed ID: 27799439
    [Abstract] [Full Text] [Related]

  • 11. Disease activity, severity, and damage in the UK Juvenile-Onset Systemic Lupus Erythematosus Cohort.
    Watson L, Leone V, Pilkington C, Tullus K, Rangaraj S, McDonagh JE, Gardner-Medwin J, Wilkinson N, Riley P, Tizard J, Armon K, Sinha MD, Ioannou Y, Archer N, Bailey K, Davidson J, Baildam EM, Cleary G, McCann LJ, Beresford MW, UK Juvenile-Onset Systemic Lupus Erythematosus Study Group.
    Arthritis Rheum; 2012 Jul 25; 64(7):2356-65. PubMed ID: 22294381
    [Abstract] [Full Text] [Related]

  • 12. Chinese SLE Treatment and Research group (CSTAR) registry: I. Major clinical characteristics of Chinese patients with systemic lupus erythematosus.
    Li M, Zhang W, Leng X, Li Z, Ye Z, Li C, Li X, Zhu P, Wang Z, Zheng Y, Li X, Zhang M, Zhang F, Zhao Y, Zeng X, CSTAR co-authors.
    Lupus; 2013 Oct 25; 22(11):1192-9. PubMed ID: 23963101
    [Abstract] [Full Text] [Related]

  • 13. Clinical and laboratory characteristics in juvenile-onset systemic lupus erythematosus across age groups.
    Massias JS, Smith EMD, Al-Abadi E, Armon K, Bailey K, Ciurtin C, Davidson J, Gardner-Medwin J, Haslam K, Hawley DP, Leahy A, Leone V, McErlane F, Mewar D, Modgil G, Moots R, Pilkington C, Ramanan AV, Rangaraj S, Riley P, Sridhar A, Wilkinson N, Beresford MW, Hedrich CM.
    Lupus; 2020 Apr 25; 29(5):474-481. PubMed ID: 32233733
    [Abstract] [Full Text] [Related]

  • 14. Analysis of clinical, immunological characteristics, damage, and survival in 300 Turkish systemic lupus erythematosus patients.
    Tekeoglu S, Temiz Karadag D, Ozdemir Isik O, Yazici A, Cefle A.
    Lupus; 2024 Mar 25; 33(3):298-311. PubMed ID: 38258530
    [Abstract] [Full Text] [Related]

  • 15. Renal damage in systemic lupus erythematosus: a comparative analysis of different age groups.
    Mak A, Mok CC, Chu WP, To CH, Wong SN, Au TC.
    Lupus; 2007 Mar 25; 16(1):28-34. PubMed ID: 17283582
    [Abstract] [Full Text] [Related]

  • 16. Late onset lupus nephritis: analysis of clinical manifestations and renal pathological features in Chinese patients.
    Tang Z, Chen D, Yang S, Zhang H, Hu W, Liu Z, Li L.
    Rheumatol Int; 2011 Dec 25; 31(12):1625-9. PubMed ID: 20535471
    [Abstract] [Full Text] [Related]

  • 17. Outcomes following mycophenolate mofetil versus cyclophosphamide induction treatment for proliferative juvenile-onset lupus nephritis.
    Smith E, Al-Abadi E, Armon K, Bailey K, Ciurtin C, Davidson J, Gardner-Medwin J, Haslam K, Hawley D, Leahy A, Leone V, McErlane F, Mewar D, Modgil G, Moots R, Pilkington C, Ramanan A, Rangaraj S, Riley P, Sridhar A, Wilkinson N, Beresford MW, Hedrich CM.
    Lupus; 2019 Apr 25; 28(5):613-620. PubMed ID: 30871425
    [Abstract] [Full Text] [Related]

  • 18. The outcome of patients with renal involvement in pediatric-onset systemic lupus erythematosus--a 20-year experience in Asia.
    Lee PY, Yeh KW, Yao TC, Lee WI, Lin YJ, Huang JL.
    Lupus; 2013 Dec 25; 22(14):1534-40. PubMed ID: 23966304
    [Abstract] [Full Text] [Related]

  • 19. Management practice and treatment outcomes of adult patients with Lupus Nephritis at the Renal Clinic of St. Paul's Hospital Millennium Medical College, Addis Ababa, Ethiopia.
    Hailu GT, Hussen SU, Getachew S, Berha AB.
    BMC Nephrol; 2022 Jun 17; 23(1):214. PubMed ID: 35715762
    [Abstract] [Full Text] [Related]

  • 20. Comparison of clinical features, disease activity, treatment and outcomes between late-onset and early-onset patients with systemic lupus erythematosus. A sex- and year at diagnosis-matched controlled study.
    Mongkolchaiarunya J, Wongthanee A, Kasitanon N, Louthrenoo W.
    Adv Rheumatol; 2023 May 01; 63(1):20. PubMed ID: 37127712
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.